title: Acute ApoA-I Milano administration induces plaque regression and stabilisation in the long term.
authors.forename: Chiara
authors.initials: C
authors.lastname: Giannarelli
authors.forename: Giovanni
authors.initials: G
authors.lastname: Cimmino
authors.forename: Borja
authors.initials: B
authors.lastname: Ibanez
authors.forename: Giulia
authors.initials: G
authors.lastname: Chiesa
authors.forename: Jaime
authors.initials: J
authors.lastname: Garcia-Prieto
authors.forename: Carlos G
authors.initials: CG
authors.lastname: Santos-Gallego
authors.forename: Matilde
authors.initials: M
authors.lastname: Alique-Aguilar
authors.forename: V
authors.initials: V
authors.lastname: Fuster
authors.forename: C
authors.initials: C
authors.lastname: Sirtori
authors.forename: J J
authors.initials: JJ
authors.lastname: Badimon
mesh_terms: D000818:Animals; D001012:Aorta, Abdominal / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D016632:Apolipoprotein A-I / Q000008:administration & dosage* / Q000235:genetics / Q000378:metabolism; D014644:Genetic Variation; D006801:Humans; D058226:Plaque, Atherosclerotic / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D011817:Rabbits; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000235:genetics / Q000378:metabolism
chemical_list: C505693:APOA1 protein, human; D016632:Apolipoprotein A-I; D011994:Recombinant Proteins